GlaxoSmithKline Pharmaceuticals Limited — Others, 28-02-2025: Action(s) initiated or orders passed

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting to address a GST demand from Punjab and Rajasthan tax authorities totaling ₹76.64 lakh (₹53.67 lakh from Punjab and ₹22.97 lakh from Rajasthan). The orders, issued for FY 2020-21, cite disallowed GST credit largely due to mismatches in input tax credits. Despite the demands, the company reported no impact on its financial operations, as it is currently evaluating the orders and plans to take necessary actions. Investors may view this as a neutral impact, with limited immediate risk to the company's financial stability.